62 related articles for article (PubMed ID: 1715479)
21. [Differential expression of cardiac immediate early and late response gene in exercise-induced and hypertensive cardiac hypertrophic remodeling].
Li ZB; Gao YQ; Tang ZS
Sheng Li Xue Bao; 1998 Oct; 50(5):551-6. PubMed ID: 11367752
[TBL] [Abstract][Full Text] [Related]
22. [Plasticity of myocardial phenotype during cardiac hypertrophy and failure].
Mercadier JJ; Lompre AM; Swynghedauw B; Schwartz K
Bull Acad Natl Med; 1993 Jun; 177(6):917-31; discussion 931-3. PubMed ID: 8221190
[TBL] [Abstract][Full Text] [Related]
23. COX-2 is involved in ET-1-induced hypertrophy of neonatal rat cardiomyocytes: role of NFATc3.
Li H; Gao S; Ye J; Feng X; Cai Y; Liu Z; Lu J; Li Q; Huang X; Chen S; Liu P
Mol Cell Endocrinol; 2014 Feb; 382(2):998-1006. PubMed ID: 24291639
[TBL] [Abstract][Full Text] [Related]
24. [Regulation of the myosin heavy chain gene expression during cardiac hypertrophy induced by pressure-overload].
Kurabayashi M; Yazaki Y
Nihon Rinsho; 1993 Jun; 51(6):1435-40. PubMed ID: 8320826
[TBL] [Abstract][Full Text] [Related]
25. SRF-dependent gene expression in isolated cardiomyocytes: regulation of genes involved in cardiac hypertrophy.
Nelson TJ; Balza R; Xiao Q; Misra RP
J Mol Cell Cardiol; 2005 Sep; 39(3):479-89. PubMed ID: 15950986
[TBL] [Abstract][Full Text] [Related]
26. Sympathetic alpha(2)-adrenoceptors prevent cardiac hypertrophy and fibrosis in mice at baseline but not after chronic pressure overload.
Gilsbach R; Schneider J; Lother A; Schickinger S; Leemhuis J; Hein L
Cardiovasc Res; 2010 Jun; 86(3):432-42. PubMed ID: 20083574
[TBL] [Abstract][Full Text] [Related]
27. Effects of long-term hydralazine treatment on myocardial structure and expression of myosin isogenes in cardiac pressure overload in rats.
Reddy DS; Singh M; Ganguly NK
Methods Find Exp Clin Pharmacol; 1996 May; 18(4):261-71. PubMed ID: 8803958
[TBL] [Abstract][Full Text] [Related]
28. The vascular smooth muscle alpha-actin gene is reactivated during cardiac hypertrophy provoked by load.
Black FM; Packer SE; Parker TG; Michael LH; Roberts R; Schwartz RJ; Schneider MD
J Clin Invest; 1991 Nov; 88(5):1581-8. PubMed ID: 1834699
[TBL] [Abstract][Full Text] [Related]
29. Rosuvastatin prevents pressure overload‑induced myocardial hypertrophy via inactivation of the Akt, ERK1/2 and GATA4 signaling pathways in rats.
Xu X; Zhang L; Liang J
Mol Med Rep; 2013 Aug; 8(2):385-92. PubMed ID: 23799547
[TBL] [Abstract][Full Text] [Related]
30. Targeted disruption of Hspa4 gene leads to cardiac hypertrophy and fibrosis.
Mohamed BA; Barakat AZ; Zimmermann WH; Bittner RE; Mühlfeld C; Hünlich M; Engel W; Maier LS; Adham IM
J Mol Cell Cardiol; 2012 Oct; 53(4):459-68. PubMed ID: 22884543
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of norepinephrine-induced cardiac hypertrophy in s100beta transgenic mice.
Tsoporis JN; Marks A; Kahn HJ; Butany JW; Liu PP; O'Hanlon D; Parker TG
J Clin Invest; 1998 Oct; 102(8):1609-16. PubMed ID: 9788975
[TBL] [Abstract][Full Text] [Related]
32. Beta-adrenergic stimulation of cardiac non-myocytes augments the growth-promoting activity of non-myocyte conditioned medium.
Long CS; Hartogensis WE; Simpson PC
J Mol Cell Cardiol; 1993 Aug; 25(8):915-25. PubMed ID: 7505339
[TBL] [Abstract][Full Text] [Related]
33. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
[TBL] [Abstract][Full Text] [Related]
34. Alterations in cardiac gene expression during ventricular remodeling following experimental myocardial infarction.
Gidh-Jain M; Huang B; Jain P; Gick G; El-Sherif N
J Mol Cell Cardiol; 1998 Mar; 30(3):627-37. PubMed ID: 9515038
[TBL] [Abstract][Full Text] [Related]
35. Myocyte hypertrophy in neonatal rat heart cultures and its regulation by serum and by catecholamines.
Simpson P; McGrath A; Savion S
Circ Res; 1982 Dec; 51(6):787-801. PubMed ID: 6216022
[TBL] [Abstract][Full Text] [Related]
36. Cardiac alpha-receptors and cardiac hypertrophy in genetic predisposition to hypertension.
Böhm M; Mende U; Schmitz W; Scholz H
Am Heart J; 1986 Dec; 112(6):1347-9. PubMed ID: 3024476
[No Abstract] [Full Text] [Related]
37. Autonomic cardiac innervation: development and adult plasticity.
Hasan W
Organogenesis; 2013; 9(3):176-93. PubMed ID: 23872607
[TBL] [Abstract][Full Text] [Related]
38. Centrally acting antihypertensive drugs: re-emergence of sympathetic inhibition in the treatment of hypertension.
Benedict CR
Curr Hypertens Rep; 1999 Aug; 1(4):305-12. PubMed ID: 10981082
[TBL] [Abstract][Full Text] [Related]
39. Sympathetic activity: modulator of myocardial hypertrophy.
Long CS; Kariya K; Karns L; Simpson PC
J Cardiovasc Pharmacol; 1991; 17 Suppl 2():S20-4. PubMed ID: 1715479
[TBL] [Abstract][Full Text] [Related]
40. The cardiac beta-myosin heavy chain isogene is induced selectively in alpha 1-adrenergic receptor-stimulated hypertrophy of cultured rat heart myocytes.
Waspe LE; Ordahl CP; Simpson PC
J Clin Invest; 1990 Apr; 85(4):1206-14. PubMed ID: 2156896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
